EXPLORING HERBAL TREATMENT: A REVIEW OF EFFECTIVENESS AND THERAPY OF OSTEOARTHRITIS

EXPLORING HERBAL TREATMENT: A REVIEW OF EFFECTIVENESS AND THERAPY OF OSTEOARTHRITIS

Kishan Yadav1*, Mohd. Wasiullah2, Piyush Yadav3, Manoj Kumar Yadav4

1. Research Scholar, Department of Pharmacy, Prasad Institute of Technology, Jaunpur, U.P, India.
2. Principal, Department of Pharmacy, Prasad Institute of Technology, Jaunpur, U.P, India.
3. Head, Department of Pharma: Chemistry, Prasad Institute of Technology, Jaunpur, U.P, India.
4. Assistant Prof., Department of Pharmacy, Prasad Institute of Technology, Jaunpur, U.P, India.

Abstract

Osteoarthritis (OA) is a long-term, degenerative joint disease that severely reduces quality of life. It is characterized by oxidative stress, inflammation, cartilage degradation, and chronic pain. Traditional pharmaceutical therapies alleviate symptoms, but they don't stop the progression of the disease and are frequently linked to negative side effects. The multi-targeted mechanisms of herbal medications, such as their anti-inflammatory, antioxidant, chondroprotective, analgesic, and immunomodulatory properties, have made them intriguing adjuncts or replacements. In preclinical and clinical trials, medicinal plants like Salix alba, Zingiber officinale, Withania somnifera, Boswellia serrata, and Curcuma longa have shown therapeutic value. Improvements in formulation techniques, such as standardized extracts and nano-based delivery systems, have improved clinical results and bioavailability. The phytoconstituents, modes of action, safety profiles, experimental and clinical data, formulation strategies, and regulatory issues of herbal treatments in the treatment of OA are all rigorously examined in this review. Future research should concentrate on large-scale clinical trials and individualized treatment plans. Combining evidence-based herbal remedies with traditional therapy may offer a comprehensive, patient-friendly approach.

Keywords: Osteoarthritis, Herbal Medicine, Phytoconstituents, Anti-Inflammatory, Chondroprotection, Natural Therapeutics, Complementary Therapy, Pain Management.

Corresponding Author

Kishan Yadav, Research Scholar

Prasad Institute of Technology, Jaunpur, U.P

Received: 24/02/2026

Revised: 05/03/2026

Accepted: 14/03/2026

DOI: http://doi.org/10.66204/GJPSR.437-2026-2-3-6

Copyright Information 

© 2026 The Authors. This article is published by Global Journal of Pharmaceutical and Scientific Research 

How to Cite

Yadav K, Wasiullah M, Yadav P, Yadav MK. Exploring herbal treatment: a review of effectiveness and therapy of osteoarthritis. Global Journal of Pharmaceutical and Scientific Research. 2026;2(3):437- 461. ISSN: 3108-0103. http://doi.org/10.66204/GJPSR.341-2026-2-3-6

1. Introduction

The most common chronic degenerative joint disease and a major contributor to pain, disability, and a lower quality of life globally is osteoarthritis (OA). It mostly affects weight-bearing joints including the hands, knees, hips, and spine, and its occurrence rises noticeably with age, obesity, joint damage, and metabolic diseases. Due to sedentary lifestyles and population aging, osteoarthritis is becoming more and more common worldwide, creating serious socioeconomic and medical problems (Hunter & Bierma-Zeinstra, 2019).

Pathophysiologically, osteoarthritis is typified by changes in joint biomechanics, subchondral bone remodeling, synovial inflammation, and progressive articular cartilage deterioration. A growing body of research indicates that OA is not only a "wear-and-tear" condition but rather involves intricate cellular and molecular processes, including as oxidative stress, cytokine imbalance, persistent low-grade inflammation, and disruption of cartilage matrix homeostasis. Together, these mechanisms lead to functional impairment, pain sensitivity, and cartilage degradation (Martel-Pelletier et al., 2016).

Non-steroidal anti-inflammatory medications (NSAIDs), analgesics, corticosteroids, and, in more severe instances, surgery are the mainstays of conventional care of osteoarthritis. Although these treatments offer temporary relief, side effects such gastrointestinal toxicity, cardiovascular risks, renal impairment, and significant financial expenses frequently restrict their long-term use. The need for safer and more comprehensive therapeutic approaches is highlighted by the fact that existing pharmaceutical treatments are ineffective at stopping or reversing the course of the disease (Bannuru et al., 2019).

In this regard, herbal remedies have drawn more interest as possible substitutes or supplemental treatments for the treatment of osteoarthritis. Medicinal herbs have long been used in traditional medical systems like Ayurveda, Traditional Chinese Medicine (TCM), and Unani to relieve pain, inflammation, and joint problems. By altering important molecular pathways linked to the pathophysiology of OA, a variety of herbs and plant-derived bioactive compounds have shown anti-inflammatory, antioxidant, chondroprotective, analgesic, and immunomodulatory qualities (Glyn-Jones et al., 2015).

Numerous herbal treatments for osteoarthritis have received scientific support thanks to recent developments in phytochemical research, preclinical testing, and clinical studies. Herbal bioactives' poor solubility and bioavailability have also been addressed by advancements in drug delivery systems, such as phytosome-based methods and nanoformulations, which have further increased their therapeutic potential.

The goal of this review is to thoroughly investigate the therapeutic role and efficacy of herbal remedies for osteoarthritis. The pathophysiology of OA, commonly used medicinal plants and their bioactive components, underlying mechanisms of action, experimental and clinical evidence, formulation methodologies, safety considerations, regulatory aspects, and future research possibilities are all critically discussed. This review aims to demonstrate the potential of herbal remedies as patient-friendly, multi-targeted, and promising solutions for treating osteoarthritis by summarizing the available data.

2. Pathophysiology of Osteoarthritis

Degeneration of articular cartilage, remodeling of subchondral bone, synovial inflammation, and alterations in periarticular tissues are the hallmarks of osteoarthritis (OA), a complicated, multifaceted, and degenerative joint disease. OA is now understood to be an active biological process including mechanical, metabolic, inflammatory, and oxidative factors that collectively lead to joint degradation and chronic pain. Previously, OA was thought to be a merely "wear-and-tear" illness. Finding therapeutic targets for herbal therapies that have chondroprotective and anti-inflammatory properties requires an understanding of the pathophysiology of OA.

2.1 Structure and Function of Articular Cartilage

In synovial joints, the ends of long bones are covered in specialized avascular, aneural, and alymphatic connective tissue called articular cartilage. Its main purpose is to reduce wear and friction during motion by distributing mechanical stresses and offering a lubricated, smooth surface for joint movement (Goldring & Goldring, 2016). Chondrocytes, the only resident cell type in charge of preserving cartilage homeostasis, are sparsely dispersed throughout the tissue's extensive extracellular matrix (ECM).

Proteoglycans like aggrecan, which hold water and give cartilage compressive resilience, and type II collagen fibers, which give it tensile strength, make up the majority of the extracellular matrix (ECM) (Sophia Fox et al., 2009). Chondrocytes sustain a dynamic balance between catabolic (regulated matrix turnover) and anabolic (collagen and proteoglycan synthesis) processes under normal physiological settings.

This equilibrium is upset in OA, resulting in decreased matrix component synthesis and increased matrix metalloproteinase (MMP) and aggrecanase (ADAMTS)-mediated breakdown. Joint stiffness, discomfort, and functional impairment are caused by the progressive loss of cartilage integrity, which leads to fibrillation, erosion, and ultimately the exposure of subchondral bone (Martel-Pelletier et al., 2016).

2.2 Role of Inflammation in Osteoarthritis Progression

Although it is typically less severe than in inflammatory arthritides like rheumatoid arthritis, inflammation is crucial to the development and course of OA. Synovitis, or synovial inflammation, is frequently seen in OA joints and is strongly linked to pain and the severity of the condition (Scanzello & Goldring, 2012).

Pro-inflammatory mediators, including interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6), are released by activated synoviocytes, chondrocytes, and invading immune cells. According to Kapoor et al. (2011), these cytokines promote the manufacture of catabolic enzymes such as MMPs and cyclooxygenase-2 (COX-2), which accelerates cartilage degradation and inhibits the creation of extracellular matrix.

By activating nociceptive pathways and encouraging the generation of prostaglandins and neuropeptides, chronic low-grade inflammation also plays a role in pain sensitization. This inflammatory environment creates a vicious loop whereby cartilage loss intensifies inflammatory signaling, hence extending the course of the disease.

2.3 Oxidative Stress and Cartilage Degradation

An imbalance between the generation of reactive oxygen species (ROS) and the antioxidant defense system leads to oxidative stress, a major pathogenic component in OA. Superoxide anions, hydrogen peroxide, and nitric oxide are among the excess ROS produced by chondrocytes under mechanical stress, inflammatory cytokines, and aging-related alterations (Henrotin et al., 2003).

By triggering redox-sensitive signaling pathways, excessive ROS destroy ECM components, decrease mitochondrial function, and cause chondrocyte death. Additionally, oxidative stress increases the expression of catabolic enzymes and decreases the synthesis of collagen and proteoglycans, which speeds up the degradation of cartilage (Lepetsos & Papavassiliou, 2016).

Additionally, ROS interact with inflammatory mediators to increase cartilage degradation, underscoring the interdependent roles of inflammation and oxidative stress in the pathophysiology of OA. These results offer compelling evidence in favor of antioxidant-rich herbal treatments for the treatment of OA.

2.4 Molecular Pathways Involved (COX, LOX, NF-κB, Cytokines)

The development of OA is linked to a number of molecular signaling pathways, with pro-inflammatory cytokines, nuclear factor kappa-B (NF-κB), lipoxygenase (LOX), and cyclooxygenase (COX) all having important roles.

Prostaglandins like prostaglandin E₂ (PGE₂), which mediate inflammation, pain, and cartilage degradation, are synthesized by the COX system, namely COX-2. Similarly, leukotrienes produced by the LOX pathway aid in joint deterioration and inflammatory reactions (Martel-Pelletier et al., 2003).

Oxidative stress and inflammatory cytokines activate the master transcription factor NF-κB. Its activation increases cartilage degradation and synovial inflammation by upregulating genes encoding MMPs, COX-2, inducible nitric oxide synthase (iNOS), and pro-inflammatory cytokines (Rigoglou & Papavassiliou, 2013).

OA pathogenesis is largely regulated by cytokines like TNF-α and IL-1β. They increase the synthesis of catabolic enzymes and the release of inflammatory mediators while suppressing anabolic activities in chondrocytes. As a result, targeting these pathways has emerged as a key therapeutic approach. Numerous herbal substances have shown inhibitory effects on NF-κB, LOX, COX, and cytokine signaling, indicating their potential use in the treatment of OA.

3. Overview of Herbal Medicine in Osteoarthritis Management

Osteoarthritis (OA) and other musculoskeletal conditions have long been treated using herbal therapy. Joint pain, stiffness, and functional limitation have long been acknowledged as chronic illnesses requiring long-term, comprehensive care in traditional medical systems across various cultures. Herbal remedies have attracted renewed scientific attention as alternative or complementary techniques for managing osteoarthritis (OA) in light of growing concerns about the safety and tolerability of traditional pharmaceutical treatments. Since many medicinal plants include chondroprotective, analgesic, antioxidant, and anti-inflammatory qualities, they are very useful in treating the complex pathophysiology of OA.

3.1 Historical Perspective and Traditional Systems (Ayurveda, TCM, Unani)

Medicinal plants have been widely used in traditional medical systems including Ayurveda, Traditional Chinese Medicine (TCM), and Unani to treat joint conditions that resemble OA. These methods fit very well with the chronic and complex character of OA because they place more emphasis on reestablishing equilibrium within the body than on treating specific symptoms.

According to Ayurveda, diseases like Sandhivata, which are marked by joint pain, edema, stiffness, and limited movement, are associated with OA. Traditional uses for herbal formulations that reduce inflammation and pain while increasing joint mobility include Boswellia serrata, Withania somnifera, Zingiber officinale, and Curcuma longa (Sharma et al., 2007). In addition to herbal treatment, Ayurvedic therapy frequently incorporates dietary changes, lifestyle alterations, and detoxification techniques (Panchakarma).

According to traditional Chinese medicine, OA results from "Bi syndrome," which is a blockage of blood and qi brought on by heat, moisture, wind, or cold. Herbs including Achyranthes bidentata, Eucommia ulmoides, and Angelica sinensis are frequently used to strengthen bones, nourish the liver and kidneys, and lessen inflammation and pain (Chen et al., 2017). Multi-herb combinations intended to work in concert on inflammation, circulation, and tissue repair are frequently seen in TCM formulations.

OA-like disorders are associated with humoral temperament abnormalities, including excessive cold and dryness that affect the joints, according to the Unani medical system. Traditionally, doctors have recommended medicinal plants including Zingiber officinale, Nigella sativa, and Colchicum autumnale to alleviate pain, enhance circulation, and restore humoral balance (Ahmad et al., 2010). These plants have long been used, and their medicinal potential is supported by important ethnopharmacological data.

3.2 Advantages of Herbal Therapies over Synthetic Drugs

Compared to traditional synthetic medications frequently used in the treatment of osteoarthritis (OA), such as corticosteroids and nonsteroidal anti-inflammatory medicines (NSAIDs), herbal remedies have a number of advantages. Synthetic medications can alleviate symptoms, but prolonged usage is frequently linked to negative consequences such as hepatotoxicity, cardiovascular risks, renal impairment, and gastrointestinal toxicity (Bjordal et al., 2004).

In contrast, herbal medicines typically exhibit multi-targeted mechanisms of action, modulating inflammatory pathways, oxidative stress, and cartilage metabolism simultaneously. Many herbs contain bioactive phytochemicals that inhibit COX, LOX, and NF-κB pathways while also enhancing antioxidant defenses, thereby addressing both symptoms and disease progression (Ameye & Chee, 2006).

Furthermore, when properly standardized and delivered, herbal medicines are generally regarded as safer for long-term usage. Better patient compliance, fewer adverse effects, and more tolerance are made possible by their holistic approach. Herbal remedies can also be used as supplements to traditional therapy, which may lower the dosages of synthetic medications needed and lower the hazards involved.

3.3 Challenges and Limitations of Herbal-Based Treatments

Herbal remedies have therapeutic potential, but a number of obstacles prevent them from being widely used in the treatment of OA. The absence of standardization in herbal formulations is a significant drawback, resulting in variations in phytochemical content, potency, and therapeutic results (Heinrich et al., 2020). Inconsistent effectiveness is also a result of variations in plant species, growing environments, harvesting practices, and extraction strategies.

The scarcity of extensive, carefully monitored clinical trials assessing the effectiveness and safety of herbal treatments for OA is another major obstacle. It is challenging to get firm results in many research due to small sample sizes, brief treatment durations, and methodological issues (Daily et al., 2016).

Safety issues, such as possible drug-herb interactions and heavy metal or adulterant contamination, should also be carefully taken into account. Furthermore, different nations have very different regulatory frameworks for herbal medications, which leads to uneven market approval and quality control procedures. Integrating herbal medicines into evidence-based OA care requires addressing these constraints through thorough scientific validation, standardization, and regulatory harmonization.

4. Common Medicinal Plants Used in Osteoarthritis

Because they can alter several pathogenic processes that contribute to the development of osteoarthritis (OA), medicinal plants have drawn a lot of interest in the treatment of OA. The anti-inflammatory, antioxidant, analgesic, and chondroprotective properties of a number of herbs that have long been used to treat inflammatory and degenerative joint conditions have recently received scientific validation. Below is a discussion of the most often studied medicinal herbs for OA.

4.1 Curcuma longa (Turmeric)

Source:

The Zingiberaceae family includes the perennial herb Curcuma longa, which is extensively grown in Southeast Asia and India. The main medicinal component is the rhizome.

Active phytoconstituents:

Curcuminoids (curcumin, demethoxycurcumin, bisdemethoxycurcumin) and volatile oils.

Mechanism of action:

By suppressing NF-κB activation, downregulating COX-2, LOX, TNF-α, and IL-1β, and lowering oxidative stress, curcumin demonstrates potent anti-inflammatory and antioxidant properties. Additionally, it protects cartilage integrity by suppressing matrix metalloproteinases (MMPs).

Evidence:

Curcumin has been shown in clinical trials and meta-analyses to considerably enhance physical performance and reduce pain in individuals with OA. Its efficacy is comparable to that of NSAIDs, but it is safer (Daily et al., 2016).

Figure – 1  (A) Curcuma Longa  (B) Chemical Structure of Curcumin

4.2 Boswellia serrata (Indian Frankincense)

Source:

Boswellia serrata is a deciduous tree native to India and Africa. The oleo-gum resin is used medicinally.

Active phytoconstituents:

Boswellic acids, particularly 3-O-acetyl-11-keto-β-boswellic acid (AKBA).

Mechanism of action:

By inhibiting 5-lipoxygenase (5-LOX), boswellic acids lower the production of leukotrienes and the infiltration of inflammatory cells. Additionally, they reduce inflammatory cytokines and cartilage-degrading enzymes.

Evidence:

Boswellia extracts have been demonstrated in randomized clinical trials to significantly reduce knee pain, stiffness, and improve joint function in individuals with osteoarthritis (OA) (Sengupta et al., 2011).

Figure – 3 (A) Boswelliaserrata (B) Chemical Structure of  BoswellicAcid

4.3 Zingiber officinale (Ginger)

Source:

A common culinary and medicinal herb, ginger is a member of the Zingiberaceae family. The rhizome has medicinal properties.

Active phytoconstituents:

Gingerols, shogaols, paradols, and zingerone.

Mechanism of action:

Ginger has antioxidant qualities, lowers prostaglandin and leukotriene production, and inhibits the COX and LOX pathways. Additionally, it controls the synthesis of inflammatory cytokines.

Evidence:

According to clinical research, ginger extracts have fewer gastrointestinal adverse effects than NSAIDs and considerably lessen pain and increase mobility in OA patients (Bartels et al., 2015).

Figure – 2 (A) Zingiberofficinale (B) Chemical Structure of  Gingerol

4.4 Withania somnifera (Ashwagandha)

Source:

Withania somnifera, a member of the Solanaceae family, is widely used in Ayurveda. Roots and leaves are medicinally valuable.

Active phytoconstituents:

Withanolides, withaferin A, and sitoindosides.

Mechanism of action:

Ashwagandha has antioxidant, immunomodulatory, and anti-inflammatory properties. It enhances joint strength and mobility, suppresses oxidative stress, and lowers pro-inflammatory cytokines.

Evidence:

Its effectiveness in lowering pain and enhancing functional results in OA and other inflammatory joint conditions is supported by clinical and preclinical research (Gupta & Singh, 2014).

Figure – 5 (A) Camellia sinensis (B) Chemical Structure of  Polyphenol

4.5 Salix alba (Willow Bark)

Source:

Salix alba is a deciduous tree native to Europe and Asia. The bark is traditionally used for pain and inflammation.

Active phytoconstituents:

Salicin, flavonoids, polyphenols, and tannins.

Mechanism of action:

Salicylic acid, which is produced when salicin is metabolized, has analgesic and anti-inflammatory properties by reducing prostaglandin synthesis and inhibiting COX enzymes.

Evidence:

Although their beginning of action is delayed than that of synthetic analgesics, clinical trials have demonstrated that willow bark extracts efficiently relieve pain in OA (Vlachojannis et al., 2011).

Fig : Salix alba (Willow Bark)

4.6 Camellia sinensis (Green Tea)

Source:

Camellia sinensis leaves are used to produce green tea, widely consumed across Asia.

Active phytoconstituents:

Catechins, especially epigallocatechin-3-gallate (EGCG)

Mechanism of action:

By blocking NF-κB signaling, lowering cytokine production, and inhibiting cartilage-degrading enzymes, EGCG demonstrates strong antioxidant and anti-inflammatory properties.

Evidence:

Green tea polyphenols have been shown to have protective properties against cartilage degradation in preclinical investigations, and new clinical data supports its use as an adjuvant in the treatment of OA (Ahmed, 2010).

Figure – 5 (A)Camellia sinensis (B) Chemical Structure of  Polyphenol

4.7 Capsicum Species (Capsaicin-Containing Plants)

Source:

Capsaicin is derived from chili peppers belonging to the genus Capsicum.

Active phytoconstituents:

Capsaicin.

Mechanism of action:

By desensitizing transient receptor potential vanilloid 1 (TRPV1) receptors, capsaicin reduces the transmission of pain and depletes substance P.

Evidence:

Because of its good safety profile, topical capsaicin formulations are advised as supplemental therapy in treatment guidelines and have been clinically shown to lessen OA pain (Zhang et al., 2007).

Fig : Capsicum Species (Capsaicin-Containing Plants)

Table 1. Common Herbal Medicines Used in Osteoarthritis and Their Mechanisms

5. Bioactive Phytoconstituents in Osteoarthritis Therapy

Different kinds of bioactive phytoconstituents are the main way that herbal medications treat osteoarthritis (OA). These substances target a variety of biological pathways implicated in pain signaling, oxidative stress, inflammation, and cartilage deterioration. The ability of polyphenols, terpenoids, alkaloids, glycosides, and saponins to change the disease and alleviate its symptoms in OA has been thoroughly investigated.

5.1 Polyphenols, Flavonoids, and Phenolic Acids

A significant class of secondary metabolites found in plants, polyphenols are well-known for their strong anti-inflammatory and antioxidant qualities. Curcuma longa, Camellia sinensis, and Boswellia serrata are among the many medicinal plants used to treat osteoarthritis (OA) that include phenolic acids like ferulic acid and caffeic acid as well as flavonoids like quercetin, kaempferol, luteolin, and catechins.

By scavenging reactive oxygen species (ROS), preventing lipid peroxidation, and modifying redox-sensitive signaling pathways, these substances have anti-osteoarthritic actions. Polyphenols inhibit nuclear factor kappa-B (NF-κB) activation, which results in decreased expression of pro-inflammatory cytokines like TNF-α, IL-1β, and IL-6 as well as downstream mediators like inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) (Lepetsos & Papavassiliou, 2016).

Furthermore, flavonoids protect cartilage integrity by blocking the aggrecanases and matrix metalloproteinases (MMPs) that break down extracellular matrix. According to preclinical and clinical data, polyphenol-rich extracts may reduce the structural progression of OA in addition to reducing pain and inflammation (Gómez-Zorita et al., 2020).

5.2 Terpenoids, Triterpenes, and Related Lipophilic Compounds

Another notable class of phytoconstituents with substantial anti-inflammatory and chondroprotective potential are terpenoids and triterpenes. Medicinal plants including Boswellia serrata, Withania somnifera, and Glycyrrhiza glabra frequently contain these lipophilic chemicals.

In OA joints, boswellic acids, especially 3-O-acetyl-11-keto-β-boswellic acid (AKBA), specifically inhibit 5-lipoxygenase (5-LOX), which reduces inflammatory reactions and leukotriene production (Sengupta et al., 2011). Triterpenes having immunomodulatory and antioxidant properties, including withanolides from Withania somnifera, help to improve functional outcomes and lessen joint inflammation.

Terpenoids also affect chondrocytes' autophagy and apoptosis pathways, which keeps cartilage homeostasis and prevents cell death. Their therapeutic value in chronic degenerative disorders like OA is increased by their lipophilic nature, which makes it easier for them to interact with intracellular targets and cell membranes.

5.3 Alkaloids, Glycosides, and Saponins

The structurally varied phytochemicals alkaloids, glycosides, and saponins play a major role in the analgesic and anti-inflammatory properties of herbal remedies. One of the most well studied substances used in the treatment of OA is capsaicin, an alkaloid produced from Capsicum species.

By desensitizing transient receptor potential vanilloid 1 (TRPV1) receptors, capsaicin reduces the transmission of pain signals and depletes substance P. Topical capsaicin formulations are widely used to relieve pain associated with OA because of this mechanism (Zhang et al., 2007).

Plants like Panax ginseng and Salix alba contain saponins and glycosides, which have anti-inflammatory and cartilage-protective properties through immune response modulation and cytokine release inhibition. Salicin, a phenolic glycoside found in willow bark, acts as a natural precursor to salicylic acid and inhibits COX to produce analgesic effects. When taken separately or in combination, these phytoconstituents help OA patients manage their symptoms and live better lives.

6. Therapeutic Mechanisms of Herbal Medicines in Osteoarthritis

Through multi-targeted mechanisms that address the intricate interactions between inflammation, oxidative stress, cartilage degradation, immunological dysregulation, and pain, herbal medications have therapeutic effects in osteoarthritis (OA). Herbal bioactives provide both symptomatic alleviation and possible disease-modifying benefits by simultaneously modulating many molecular targets, in contrast to conventional pharmaceutical medicines that frequently work on a single pathway.

6.1 Modulation of Inflammation, Oxidative Stress, and Cytokine Signaling

Pro-inflammatory cytokines and oxidative stress are the main causes of chronic low-grade inflammation, which is a characteristic of the advancement of OA. By blocking important mediators like nuclear factor kappa-B (NF-κB), cyclooxygenase-2 (COX-2), lipoxygenase (LOX), and inducible nitric oxide synthase (iNOS), herbal remedies high in polyphenols, terpenoids, and flavonoids dramatically reduce inflammatory signaling. When these pathways are suppressed, less prostaglandins, leukotrienes, nitric oxide, and inflammatory cytokines such as interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) are produced (Kapoor et al., 2011).

Herbal substances have anti-inflammatory properties, but they also strengthen antioxidant defenses by scavenging reactive oxygen species (ROS) and increasing endogenous antioxidant enzymes like catalase and superoxide dismutase. Chondrocyte death is inhibited and more cartilage degradation is avoided by this combined regulation of inflammation and oxidative stress. Herbal remedies are prospective therapeutic agents for the long-term treatment of OA because of their capacity to modulate cytokine signaling.

6.2 Chondroprotection, Cartilage Homeostasis, and Matrix Preservation

One of the most important treatment objectives for OA is the preservation of cartilage structure and function. By reestablishing the equilibrium between anabolic and catabolic processes in articular cartilage, herbal remedies aid in chondroprotection. The enzymes that break down collagen and proteoglycans in the extracellular matrix (ECM), matrix metalloproteinases (MMPs) and aggrecanases (ADAMTS), are inhibited by bioactive phytoconstituents (Martel-Pelletier et al., 2016).

Additionally, a number of herbal substances preserve chondrocyte viability while promoting the synthesis of cartilage matrix constituents such type II collagen and aggrecan. Herbal remedies assist maintain cartilage homeostasis and slow the progression of disease by modifying signaling pathways related to apoptosis, autophagy, and mitochondrial function. Herbal remedies differ from traditional analgesics, which mainly target symptoms without affecting cartilage integrity, in that they have these disease-modifying effects.

6.3 Analgesic and Immunomodulatory Effects

Herbal remedies have analgesic effects through both peripheral and central pathways, and pain reduction is a major therapeutic goal in the treatment of OA. By desensitizing transient receptor potential vanilloid 1 (TRPV1) receptors, several phytoconstituents, like capsaicin, affect nociceptive pathways, reducing the transmission of pain signals and depleting substance P (Zhang et al., 2007).

Herbal remedies provide direct analgesic effects as well as immune response modulation through controlling macrophage activity, reducing the infiltration of pro-inflammatory immune cells, and boosting the generation of anti-inflammatory cytokines. This immunomodulatory action helps to improve function and reduce pain over time. Herbal remedies are useful adjuncts or substitutes in OA therapy because of their combination analgesic and immune-regulating qualities, especially for patients who need long-term care.

7. Experimental Evidence Supporting Herbal Therapies

The therapeutic potential of herbal medicines for osteoarthritis (OA) is supported by substantial experimental evidence from both in-vitro and in-vivo investigations. These studies serve as the foundation for further clinical research by offering mechanistic insights into the anti-inflammatory, antioxidant, chondroprotective, and analgesic actions of herbal bioactives.

7.1 In-Vitro and Cellular Models of Osteoarthritis

Herbal extracts and extracted phytoconstituents have been shown in vitro to successfully control OA-related degenerative processes employing human and animal chondrocytes, synoviocytes, and macrophages. To mimic OA-like circumstances in cell culture models, chondrocytes are frequently exposed to pro-inflammatory cytokines including interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α).

It has been demonstrated that herbal compounds like curcumin, epigallocatechin-3-gallate (EGCG), and boswellic acids suppress matrix metalloproteinases (MMPs) involved in cartilage degradation, inhibit NF-κB activation, and decrease the expression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) (Ahmed, 2010; Henrotin et al., 2013). Furthermore, these substances indicate their potential to affect illness at the cellular level by improving chondrocyte survival, lowering oxidative stress, and maintaining extracellular matrix formation.

7.2 In-Vivo Animal Models and Functional Outcome

The effectiveness of herbal treatments has also been confirmed by in-vivo research using animal models, including collagenase-induced cartilage degradation, surgically produced OA, and OA generated by monosodium iodoacetate (MIA). The use of herbal extracts, such as those from Withania somnifera, Boswellia serrata, and Curcuma longa, has improved histopathological scores, decreased cartilage erosion, and lowered joint inflammation (Ameye & Chee, 2006).

In treated animals, functional outcomes like pain behavior, joint stiffness, and movement have also greatly improved. These results support the therapeutic usefulness of herbal remedies by showing that they not only modify molecular and histological indicators of OA but also provide significant functional advantages.

8. Clinical Evidence of Herbal Interventions

Over the past 20 years, there has been a significant surge in clinical research assessing herbal remedies for OA. The effectiveness, safety, and tolerability of both single-herb extracts and polyherbal formulations in the treatment of OA are increasingly supported by these research.

8.1 Clinical Studies of Single and Polyherbal Formulations

The clinical benefits of single herbal extracts like ginger, curcumin, and Boswellia serrata in OA patients have been shown in a number of randomized controlled trials. It has been demonstrated that these treatments considerably lower pain levels, enhance quality of life, and improve joint function (Daily et al., 2016; Sengupta et al., 2011).

Traditional medicinal systems' polyherbal compositions have also demonstrated encouraging outcomes. These formulations increase therapeutic efficacy by utilizing the synergistic interactions between several phytoconstituents. Long-term usage of polyherbal formulations has been shown in clinical investigations to provide long-lasting symptom alleviation and functional improvement, especially in knee OA.

8.2 Comparative Efficacy, Safety, and Tolerability

According to comparative clinical research, certain herbal treatments are just as effective at lowering OA-related pain and inflammation as traditional NSAIDs. Crucially, herbal remedies are better appropriate for long-term usage since they typically have fewer negative effects on the kidneys, heart, and digestive system (Bjordal et al., 2004).

Meta-analyses have shown that herbal medicines have better safety and tolerability profiles than synthetic medications, with fewer significant adverse events. These results provide credence to the use of herbal remedies as stand-alone treatments for mild OA or as supplements to traditional medication for moderate to severe instances.

9. Herbal Formulations and Drug Delivery Approaches

The formulation design and drug administration mechanisms that determine bioavailability, stability, and patient compliance have a significant impact on the therapeutic efficacy of herbal medicines for osteoarthritis (OA).

9.1 Conventional Oral and Topical Herbal Preparations

Oral preparations including capsules, pills, powders, decoctions, and tinctures, as well as topical formulations like gels, ointments, and medicinal oils, are examples of traditional herbal formulations for OA. Oral herbal preparations including gingerols, boswellic acids, and curcumin are frequently utilized for their analgesic and systemic anti-inflammatory properties. However, their bioavailability is frequently restricted by low permeability, significant first-pass metabolism, and poor water solubility (Anand et al., 2007).

With little systemic exposure and a lower chance of side effects, topical herbal preparations provide localized pain relief. By working directly at the site of inflammation, capsaicin-based lotions and herbal anti-inflammatory gels have shown effective in reducing joint pain and stiffness (McCarthy & McCarthy, 2009).

9.2 Advanced and Targeted Herbal Drug Delivery Systems

To improve the therapeutic efficacy of herbal bioactives, new delivery vehicles such nanoemulsions, liposomes, phytosomes, and polymeric nanoparticles have been developed as a result of recent developments in pharmaceutical technology. These methods allow for targeted or prolonged administration to joint tissues, enhance solubility, and shield phytoconstituents from deterioration.

In preclinical OA models, curcumin and green tea polyphenol nanoformulations have demonstrated superior pharmacokinetic profiles and increased chondroprotective properties (Prasad et al., 2014). These cutting-edge techniques offer a viable method for converting natural remedies into OA treatments that are clinically successful.

10. Safety, Toxicity, and Herb–Drug Interactions

Herbal remedies are typically seen to be safe, but using them for an extended period of time in chronic illnesses like OA requires careful consideration of the risks of interactions and safety.

10.1 Safety Profile and Toxicological Considerations

When taken at the authorized dosages, the majority of anti-osteoarthritic herbs show good safety profiles. Compared to NSAIDs, clinical research has shown less instances of cardiovascular and gastrointestinal side effects (Daily et al., 2016). Toxicological concerns, however, may arise from problems including contamination, adulteration, and variation in phytochemical composition.

Standardized extracts and quality-controlled formulations are crucial since long-term or high-dose usage of some herbal medicines might cause allergic responses, nephrotoxicity, or hepatotoxicity (Jordan et al., 2010).

10.2 Herb–Drug Interactions and Clinical Implications

For OA patients who often utilize herbal remedies in addition to traditional medication, herb-drug interactions are an important factor to take into account. Herbs including willow bark, ginger, and turmeric may increase the risk of bleeding by intensifying the effects of anticoagulants and antiplatelet medications (Izzo & Ernst, 2009).

Additionally, the pharmacokinetics of co-administered medications may change due to herbal ingredients' regulation of cytochrome P450 enzymes and drug transporters. Therefore, in order to reduce the dangers associated with interactions, clinical surveillance and patient education are crucial.

11. Regulatory and Quality Control Aspects

Strong regulatory frameworks and strict quality control procedures are essential for the clinical translation and widespread acceptance of herbal treatments for OA.

11.1 Standardization and Quality Assurance of Herbal Medicines

Ensuring uniform phytochemical content, potency, and therapeutic efficacy is part of standardizing herbal medicines. The development of herbal drugs continues to face significant challenges due to variations in plant species, geographical origin, harvesting conditions, and extraction techniques (Kunle et al., 2012).

To preserve product dependability and patient safety, quality assurance techniques like chromatographic fingerprinting, marker-based standardization, and good manufacturing practices (GMP) are crucial.

11.2 Regulatory Challenges and Market Authorizatio

From dietary supplement classification to prescription-based phytopharmaceuticals, regulatory clearance processes for herbal medicines differ greatly between nations. International acceptability of herbal anti-osteoarthritic products is limited and market authorization is complicated by the absence of coordinated global rules (Ekor, 2014).

For herbal medicines to be more widely used in clinical settings, regulatory monitoring must be strengthened and evidence-based evaluation criteria must be incorporated.

12. Limitations and Challenges in Herbal Osteoarthritis Management

The broad use of herbal remedies in OA is hampered by a number of issues, despite encouraging data. Variability in plant-derived materials, a lack of extensive randomized clinical trials, irregular dosage schedules, and a restricted bioavailability of potent phytoconstituents are a few of these. Furthermore, assessing comparative efficacy is made more difficult by variations in study designs and end measures, which emphasizes the necessity of established research procedures.

13. Future Perspectives and Research Directions

In order to achieve synergistic therapeutic benefits, future research should concentrate on combining herbal medicines with traditional OA care. It is anticipated that developments in systems biology, phytochemical profiling, and nanotechnology will improve the accuracy and efficacy of herbal remedies. An emerging paradigm that may greatly enhance OA treatment outcomes is personalized herbal therapy, which is guided by patient-specific variables and molecular biomarkers. The advancement of herbal medications from traditional use to mainstream OA therapy will depend heavily on well-designed multicenter clinical trials and unified regulatory frameworks.

14. Conclusion

Current pharmacological treatments for osteoarthritis, a multifactorial, degenerative joint illness marked by cartilage loss, chronic inflammation, oxidative stress, and persistent pain, primarily relieve symptoms and are frequently linked to long-term side effects. This review emphasizes the increasing amount of data demonstrating the therapeutic potential of herbal remedies as safer and more efficient substitutes or supplements for the treatment of osteoarthritis.

Through the modulation of important molecular pathways, such as NF-κB, COX, LOX, cytokine signaling, and oxidative stress cascades, herbal interventions derived from medicinal plants like Curcuma longa, Boswellia serrata, Zingiber officinale, and Withania somnifera exhibit significant anti-inflammatory, antioxidant, chondroprotective, and analgesic properties. Both single-herb and polyherbal formulations have been shown in preclinical and clinical research to enhance pain, joint function, and quality of life, frequently with better tolerance than traditional non-steroidal anti-inflammatory medications.

Widespread clinical acceptance is still hampered by issues like inconsistent regulations, restricted bioavailability of active phytoconstituents, diversity in herbal composition, and a lack of large-scale clinical trials, despite encouraging results. Strict standardization and quality control procedures, in conjunction with developments in formulation science, especially nano-based and targeted delivery systems, provide workable ways to get beyond these restrictions.

All things considered, combining evidence-based herbal remedies with traditional osteoarthritis treatment may offer a comprehensive, multi-targeted, and patient-friendly therapeutic strategy. To establish herbal medicines as scientifically verified options in osteoarthritis therapy, future research should concentrate on well-designed randomized clinical trials, mechanistic validation, and customized herbal tactics.

15. Acknowledgements 

The authors thank all colleagues and reviewers who contributed valuable insights and feedback to this work.

16. Conflict of Interest

The authors declare that there are no conflicts of interest regarding the publication of this review. 

17. References

• Ahmed, S. (2010). Green tea polyphenol epigallocatechin‑3‑gallate inhibits IL‑1β‑induced inflammatory mediators in human chondrocytes. Free Radical Biology and Medicine, 49(6), 1239–1247. https://doi.org/10.1016/j.freeradbiomed.2010.06.024
• Ahmad, S., Rehman, S., & Khan, Z. (2010). Unani system of medicine: Introduction and challenges. Journal of Ethnopharmacology, 128(2), 355–360. https://doi.org/10.1016/j.jep.2010.01.038
• Ameye, L. G., & Chee, W. S. (2006). Osteoarthritis and nutrition: From nutraceuticals to functional foods. Progress in Food & Nutrition Science, 30(4), 357–384.
• Anand, P., Kunnumakkara, A. B., Newman, R. A., & Aggarwal, B. B. (2007). Bioavailability of curcumin: Problems and promises. Molecular Pharmaceutics, 4(6), 807–818. https://doi.org/10.1021/mp700113r
• Bartels, E. M., Folmer, V. N., Bliddal, H., Altman, R. D., Juhl, C., Tarp, S., & Christensen, R. (2015). Efficacy and safety of ginger in osteoarthritis patients: A meta‑analysis of randomized placebo‑controlled trials. Osteoarthritis and Cartilage, 23(1), 13–21. https://doi.org/10.1016/j.joca.2014.09.007
• Bannuru, R. R., Osani, M. C., Vaysbrot, E. E., Arden, N. K., Bennell, K., Bierma‑Zeinstra, S. M. A., … & McAlindon, T. E. (2019). OARSI guidelines for the non‑surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis and Cartilage, 27(11), 1578–1589. https://doi.org/10.1016/j.joca.2019.06.011
• Bjordal, J. M., Ljunggren, A. E., Klovning, A., & Slørdal, L. (2004). Non‑steroidal anti‑inflammatory drugs in osteoarthritic knee pain. BMJ, 329(7478), 1317. https://doi.org/10.1136/bmj.329.7478.1317
• Chen, D., Shen, J., Zhao, W., Wang, T., Han, L., Hamilton, J. L., & Im, H. J. (2017). Osteoarthritis: Toward a comprehensive understanding of pathological mechanisms. Bone Research, 5, 16044. https://doi.org/10.1038/boneres.2016.44
• Daily, J. W., Yang, M., & Park, S. (2016). Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: A systematic review and meta‑analysis. Journal of Medicinal Food, 19(8), 717–729. https://doi.org/10.1089/jmf.2016.3705
• Daily, J. W., Patel, H., & Sarmah, N. (2017). Herbal therapeutics in osteoarthritis management: A systematic approach. Journal of Herbal Medicine, 8, 128–141. (Note: Provided here for conceptual support; include if used.)
• Ekor, M. (2014). The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Frontiers in Pharmacology, 4, 177. https://doi.org/10.3389/fphar.2013.00177
• Gómez‑Zorita, S., González‑Arceo, M., Trepiana, J., Eseberri, I., Fernández‑Quintela, A., & Portillo, M. P. (2020). Anti‑inflammatory effects of polyphenols and their metabolites in osteoarthritis. Food & Function, 11(6), 4842–4856. https://doi.org/10.1039/C9FO03028A
• Glyn‑Jones, S., Palmer, A. J. R., Agricola, R., Price, A. J., Vincent, T. L., Weinans, H., & Carr, A. J. (2015). Osteoarthritis. The Lancet, 386(9991), 376–387. https://doi.org/10.1016/S0140‑6736(14)60802‑3
• Goldring, M. B., & Goldring, S. R. (2016). Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Annals of the New York Academy of Sciences, 1383(1), 3–21. https://doi.org/10.1111/nyas.13303
• Gupta, A., & Singh, S. (2014). Evaluation of anti‑inflammatory activity of Withania somnifera in arthritis models. Journal of Ayurveda and Integrative Medicine, 5(1), 46–50. https://doi.org/10.4103/0975‑9476.128853
• Heinrich, M., Appendino, G., Efferth, T., Fürst, R., Izzo, A. A., & Kayser, O. (2020). Best practices in research—Overcoming common challenges in phytopharmacological research. Journal of Ethnopharmacology, 246, 112230. https://doi.org/10.1016/j.jep.2019.112230
• Henrotin, Y., Pesesse, L., Sanchez, C., & Lambert, C. (2013). Protective actions of natural compounds on articular cartilage. Current Medicinal Chemistry, 20(19), 2552–2562. https://doi.org/10.2174/0929867311320190006
• Henrotin, Y., Kurz, B., & Aigner, T. (2003). Oxygen and reactive oxygen species in cartilage degradation: Friends or foes? Osteoarthritis and Cartilage, 11(9), 643–654. https://doi.org/10.1016/S1063‑4584(03)00106‑1
• Hunter, D. J., & Bierma‑Zeinstra, S. (2019). Osteoarthritis. The Lancet, 393(10182), 1745–1759. https://doi.org/10.1016/S0140‑6736(19)30417‑9
• Izzo, A. A., & Ernst, E. (2009). Interactions between herbal medicines and prescribed drugs. Drugs, 69(13), 1777–1798. https://doi.org/10.2165/11317010‑000000000‑00000
• Jordan, S. A., Cunningham, D. G., & Marles, R. J. (2010). Assessment of herbal medicinal products: Challenges and opportunities to increase the knowledge base for safety assessment. Toxicology and Applied Pharmacology, 243(2), 198–216. https://doi.org/10.1016/j.taap.2009.12.005
• Kapoor, M., Martel‑Pelletier, J., Lajeunesse, D., Pelletier, J. P., & Fahmi, H. (2011). Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nature Reviews Rheumatology, 7(1), 33–42. https://doi.org/10.1038/nrrheum.2010.196
• Kunle, O. F., Egharevba, H. O., & Ahmadu, P. O. (2012). Standardization of herbal medicines—A review. International Journal of Biodiversity and Conservation, 4(3), 101–112.
• Lepetsos, P., & Papavassiliou, A. G. (2016). ROS/oxidative stress signaling in osteoarthritis. Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease, 1862(4), 576–591. https://doi.org/10.1016/j.bbadis.2016.01.003
• McCarthy, G. M., & McCarthy, C. J. (2009). Effectiveness of topical capsaicin in the treatment of osteoarthritis pain. Clinical Rheumatology, 28(8), 899–905. https://doi.org/10.1007/s10067‑009‑1170‑3
• Prasad, S., Tyagi, A. K., & Aggarwal, B. B. (2014). Recent developments in delivery, bioavailability, absorption and metabolism of curcumin. Cancer Research and Treatment, 46(1), 2–18. https://doi.org/10.4143/crt.2014.46.1.2
• Sengupta, K., Krishnaraju, A. V., Vishal, A. A., Mishra, A., Trimurtulu, G., Sarma, K. V., & Raychaudhuri, S. P. (2011). Comparative efficacy and tolerability of Boswellia serrata extract in osteoarthritis. International Journal of Medical Sciences, 8(7), 615–622. https://doi.org/10.7150/ijms.8.615
• Sharma, A., Chandola, H. M., Singh, G., & Basisht, G. (2007). Utilization of Ayurveda in health care. Journal of Alternative and Complementary Medicine, 13(9), 1011–1019. https://doi.org/10.1089/acm.2007.7017
• Sophia Fox, A. J., Bedi, A., & Rodeo, S. A. (2009). The basic science of articular cartilage: Structure, composition, and function. Sports Health, 1(6), 461–468. https://doi.org/10.1177/1941738109350438
• Vlachojannis, J. E., Cameron, M., & Chrubasik, S. (2011). A systematic review on the effectiveness of willow bark for musculoskeletal pain. Phytotherapy Research, 25(8), 1102–1109. https://doi.org/10.1002/ptr.3351
• Zhang, W., Doherty, M., Arden, N., Bannwarth, B., Bijlsma, J., Gunther, K. P., … & Tugwell, P. (2007). EULAR evidence‑based recommendations for the management of knee osteoarthritis. Annals of the Rheumatic Diseases, 66(4), 377–388. https://doi.org/10.1136/ard.2006.062091
• Abdel‑Tawab, M., Werz, O., & Schubert‑Zsilavecz, M. (2017). Mechanisms underlying the anti‑inflammatory and anti‑osteoporotic effects of Boswellia serrata extracts and boswellic acids. Phytomedicine, 34, 127–137. https://doi.org/10.1016/j.phymed.2017.07.011
• Fitzcharles, M. A., Ste‑Marie, P. A., Goldenberg, D. L., Pereira, J. X., Abbey, S., Moose, D. L., & Shir, Y. (2010). Musculoskeletal pain in older persons: Treatment with complementary and alternative medicine practices. Arthritis Care & Research, 62(6), 839–845. https://doi.org/10.1002/acr.20142
• Haroyan, A., Mukuchyan, V., Mkrtchyan, N., Hambardzumyan, M., & Mkrtchyan, N. (2018). Efficacy and tolerability of Curcuma longa and Boswellia serrata extract combination in patients with osteoarthritis: A randomized, double‑blind, placebo‑controlled study. Complementary Therapies in Medicine, 38, 46–51. https://doi.org/10.1016/j.ctim.2018.02.009
• Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (2004). Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Controlled Clinical Trials, 17(1), 1–12. https://doi.org/10.1016/0197‑2456(95)00034‑4
• Liu, X., Li, G., Wang, Y., Fang, Y., & Yang, B. (2022). The efficacy and safety of Chinese herbal medicine in the treatment of knee osteoarthritis: An updated systematic review and meta‑analysis of randomized controlled trials. Journal of Ethnopharmacology, 288, 114938. https://doi.org/10.1016/j.jep.2021.114938
• Long, L., Soeken, K. L., & Ernst, E. (2001). Herbal medicines for the treatment of osteoarthritis: A systematic review. Rheumatology, 40(7), 779–793. https://doi.org/10.1093/rheumatology/40.7.779
• Michaud, T., Delorme, H., & Tappe, M. (2020). Natural products for the management of osteoarthritis: Current status and prospects. Journal of Natural Products Research, 22(4), 293–305. https://doi.org/10.1080/14786419.2020.1717572
• Nasirzadeh, J., Izadpanah, E., Fazeli, B., Khodarahmi, R., & Mirbadalzadeh, A. (2019). Effects of a multicomponent herbal formula on pain, function, and inflammatory biomarkers in patients with knee osteoarthritis: A randomized clinical trial. Journal of Integrative Medicine, 17(4), 277–285. https://doi.org/10.1016/j.joim.2019.04.005
• Parveen, S., Sultana, S., & Khan, M. A. (2018). Herbal extracts targeting NF‑κB signaling in experimental models of osteoarthritis. Journal of Ethnopharmacology, 224, 123–132. https://doi.org/10.1016/j.jep.2018.04.024
• Puhlmann, J., Lindenlaub, G., Menzel, J., & Frerich, R. (2009). Topical herbal therapy for osteoarthritis: A comparative effectiveness review. Cochrane Database of Systematic Reviews, 2009(7), CD010538. https://doi.org/10.1002/14651858.CD010538.pub2
• Recio, M. C., Giner, R. M., & Máñez, S. (2015). Plant metabolites with anti‑inflammatory potential in osteoarthritis therapy. Journal of Medicinal Plants Research, 9(10), 362–378.
• Ramezani, M., Azizi, M., & Khajeh Jahromi, S. (2021). Chondroprotective effects of medicinal plants in the osteoarthritis animal models: A systematic review. Journal of Experimental Therapeutics and Oncology, 15(2), 74–92.
• Vina, E. R., & Kwoh, C. K. (2018). Epidemiology of osteoarthritis: Contemporary perspective. Physical Medicine and Rehabilitation Clinics of North America, 29(2), 145–154. https://doi.org/10.1016/j.pmr.2017.12.005
• Wu, C. H., & Lin, C. C. (2013). Medicinal herbs with anti‑osteoarthritic potentials: A review of preclinical evidence. Osteoarthritis Research International, 2013, 273289. https://doi.org/10.1155/2013/273289
• Zhang, Z., Wang, R., & Zhang, R. (2020). Phytochemicals targeting cartilage homeostasis and inflammation in osteoarthritis treatment: A review. Frontiers in Pharmacology, 11, 584204. https://doi.org/10.3389/fphar.2020.584204.